The results showed substantially decreased numbers of Ki67-positive tumor cells and significantly increased numbers of cleaved-caspase 3-positive cells in the group treated with BMN673 and JQ1 compared to those in the vehicle group and the monotherapy groups (Supplementary Figures 9A, B). The gene discussed is CASP3; the disease is neoplasm.